Fragen? Antworten! Siehe auch: Alternativlos
“There’s very little distance between what Pharma wants and what the U.S. is demanding,” said Rohit Malpini, director of policy for Doctors Without Borders.
Es geht vor allem um den Zugang zu Generika und Biologics, und TPP (und damit vermutlich auch TTIP) würden den Zugang zu Medikamenten weltweit künstlich verknappen und verteuern.But Malpani of Doctors Without Borders said U.S. negotiators have basically functioned as drug lobbyists. […]“We consider this the worst-ever agreement in terms of access to medicine,” he said. “It would create higher drug prices around the world—and in the U.S., too.